Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.89 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.84 |
| ▸ | PPARG | P37231 | 7/20 | 0.84 |
| ▸ | PPARD | Q03181 | 7/20 | 0.84 |
| ▸ | PPARA | Q07869 | 7/20 | 0.84 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.84 |
| ▸ | TSHR | P16473 | 4/20 | 0.84 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.84 |
| ▸ | FABP4 | P15090 | 3/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.84 |
| ▸ | TLR2 | O60603 | 2/20 | 0.84 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.84 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.84 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.84 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.84 |
| ▸ | MEN1 | O00255 | 1/20 | 0.84 |
| ▸ | ESR1 | P03372 | 1/20 | 0.84 |
| ▸ | PDE4A | P27815 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexanoate SCHEMBL9856858 | 0.97 | — | — | |
| Myristic Acid SCHEMBL28656242 | 0.94 | GPR84 (0.94) | AKR1B1GPR84PPARGPPARDPPARA | |
| Palmitic Acid SCHEMBL27513709 | 0.94 | GPR84 (0.94) | AKR1B1GPR84PPARGPPARDPPARA | |
| Dodecanoate SCHEMBL27496427 | 0.94 | GPR84 (0.94) | AKR1B1GPR84PPARGPPARDPPARA | |
| Stearic Acid SCHEMBL20658928 | 0.94 | GPR84 (0.94) | AKR1B1GPR84PPARGPPARDPPARA | |
| Hexanoate SCHEMBL1330703 | 0.94 | — | — | |
| Hexanoate SCHEMBL29695652 | 0.94 | — | — | |
| Adipic Acid SCHEMBL2065667 | 0.94 | AKR1B1 (1.00) | AKR1B1GPR84PPARGPPARDPPARA | |
| Adipic Acid SCHEMBL31546519 | 0.94 | AKR1B1 (1.00) | AKR1B1GPR84PPARGPPARDPPARA | |
| Hexanoate SCHEMBL4619316 | 0.94 | AKR1B1 (1.00) | AKR1B1GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6682896-B1 | ISOLATED POLYCLONAL ANTIBODY HAVING NEUTRALIZING BINDING AFFINITY FOR SAID PEPTIDES; DIAGNOSTIC OR PROGNOSTIC ASSAY WHERE PATIENT RECEIVING IFN-BETA THERAPY CAN BE ASSESSED FOR PRODUCTION OF IFN-BETA NEUTRALIZING ANTIBODIES | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-01-27 | — | — | US | disclosed |
| US-6268472-B1 | ANTIGENIC PEPTIDE HAVING SEQUENCE IDENTITY WITH P17 GAG PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS; VACCINES AGAINST ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) | CEL SCI CORPORATION | 2001-07-31 | — | — | US | disclosed |
| US-6258945-B1 | NUCLEIC ACID WHICH CODES FOR PEPTIDE OF DEFINED AMINO ACID SEQUENCE; FOR DIAGNOSIS, VACCINES, AND THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS | VIRAL TECHNOLOGIES INC | 2001-07-10 | — | — | US | disclosed |
| US-6111068-A | FROM THE P-17 GAG PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS; DIAGNOSIS; VACCINES; VIRICIDES; PROPHYLAXIS AND THERAPY FOR TREATING OR SUPPRESSING ACQUIRED IMMUNE DEFICIENCY SYNDROME | VIRAL TECHNOLOGIES, INC. (US) | 2000-08-29 | — | — | US | disclosed |
| US-6093400-A | CAPABLE OF INDUCING IMMUNE RESPONSE WHEN ADMINISTERED TO A PERSON SUFFERING FROM AIDS OR AT RISK FOR AIDS | CEL SCI CORPORATION (US) | 2000-07-25 | — | — | US | disclosed |
| EP-0969864-A1 | HIV P-17 PEPTIDE FRAGMENT, COMPOSITIONS CONTAINING AND METHODS FOR PRODUCING AND USING SAME | Viral Technologies, Inc. (US) | 2000-01-12 | — | — | EP | disclosed |
| US-6010864-A | Peptides representing epitopic sites on r-IFN-β,antibodies thereto, and uses thereof | SCHERING AKTIENGELLSCHAFT (DE) | 2000-01-04 | — | — | US | disclosed |
| US-5869603-A | AMINO ACID SEQUENCES OF SYNTHETIC PEPTIDES BINDING TO NEUTRALIZING ANTIBODIES AGAINST RECOMBINANT INTERFERON-BETA; FOR DETECTION AND INHIBITION OF ANTIBODIES IN PATIENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-02-09 | — | — | US | disclosed |
| WO-1998006429-A1 | HIV P-17 PEPTIDE FRAGMENT, COMPOSITIONS CONTAINING AND METHODS FOR PRODUCING AND USING SAME | VIRAL TECHNOLOGIES, INC. (US) | 1998-02-19 | — | — | WO | disclosed |
| US-5702707-A | A POLYPEPTIDE INCLUDING AMINO ACID SEQUENCE EXTENDING FROM POSITION 92 TO 109 OF P17 GAG PROTEIN OF HIV-1, TOTAL NUMBER OF AMINO ACID DOES NOT EXCEED ABOUT 40; BASIS FOR VACCINE | VIRAL TECHNOLOGIES, INC. (US) | 1997-12-30 | — | — | US | disclosed |
| US-4804746-A | ADMINISTERING A DECAPEPTIDE AS A HAPTEN WITH A CARRIER AND A HAPTEN-CARRIER BINDER | JAPANESE FOUNDATION FOR CANCER RESEARCH (JP) | 1989-02-14 | — | — | US | disclosed |
| EP-0294390-A1 | PEPTIDES AFFECTING BLOOD PRESSURE REGULATION | TRITON BIOSCIENCES INC. (US) | 1988-12-14 | — | — | EP | disclosed |
| US-4772684-A | HYPOTENSIVE OR HYPERTENSIVE | TRITON BIOSCIENCES, INC. (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0246829-A2 | HTLV-III virus related peptides, antibodies to the peptides, vaccines, passive and active immunization against AIDS virus and diagnostic test for the serological detection of the AIDS virus | VIRAL TECHNOLOGIES, INC. (US) | 1987-11-25 | — | — | EP | disclosed |
| WO-1987005029-A2 | PEPTIDES AFFECTING BLOOD PRESSURE REGULATION | TRITON BIOSCIENCES INC (US) | 1987-08-27 | — | — | WO | disclosed |
| WO-1987005029-A1 | PEPTIDES AFFECTING BLOOD PRESSURE REGULATION | TRITON BIOSCIENCES INC. (US) | 1987-08-27 | — | — | WO | disclosed |
| US-4572800-A | ANTIGEN COMPRISING PEPTIDE BOUND TO CARRIER PROTEIN VIA COUPLING AGENT | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-02-25 | — | — | US | disclosed |
| US-4525300-A | Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies | JAPANESE FOUNDATION FOR CANCER RESEARCH (JP) | 1985-06-25 | — | — | US | disclosed |
| US-4474754-A | Human interferon-related peptides, antigens, antibodies and process for preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-02 | — | — | US | disclosed |
| EP-0107053-A2 | Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies | JAPANESE FOUNDATION FOR CANCER RESEARCH (JP) | 1984-05-02 | — | — | EP | disclosed |